Radx tech project no. 2643 - pathogendx, INC. - pathogendx covid-19 microarray clade variant detection technology
Ended Definitive Contract Awarded Last action
- Contract number
- 75N92021C00001
- Awardee
-
Pathogendx Inc. UEI F5MNXH19HA55
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $9,509,707
Award facts
- Opportunity
-
- RADx Tech Project No. 2643 - PathogenDx, Inc. - PathogenDx COVID-19 MicroArray Clade Variant Detection Technology. Award Notice · Posted Feb 23, 2021
- Contract value 100% obligated
- $9,509,707.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Scottsdale, AZ 85260, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $590,553 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $1,342,000 | |
| Original award | $7,577,154 |
About this award
Pathogendx, Inc. was awarded a $9,509,707 definitive firm fixed price contract by the National Institutes of Health's National Heart, Lung and Blood Institute to deliver their COVID-19 microarray clade variant detection technology under project number 2643. As a self-certified small disadvantaged business, Pathogendx will provide their pathogen detection array to support the National Institutes of Health's efforts to track genetic variants of SARS-CoV-2. Performance will occur in Scottsdale, Arizona through February 2023. No set-aside designation was applied to this award to the manufacturer Pathogendx.
Quick answers
Who was awarded contract 75N92021C00001?
75N92021C00001 was awarded to Pathogendx Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on February 22, 2021.
How much is contract 75N92021C00001 worth?
The government has obligated $9,509,707 on 75N92021C00001.
Was contract 75N92021C00001 competed?
The extent of competition for 75N92021C00001 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award